Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011581 · ClinicalTrials.gov registry record
Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 16
- Enrollment target
NCT02011581 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 16 participants.
The verdict
NCT02011581 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about how our body produces sugar, breaks down fat for fuel, and makes insulin (the major hormone that controls the production of blood sugar and fat breakdown) during a 24-hour day and how body fat and muscle are involved in these processes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02011581
The ClinicalTrials.gov registry entry for NCT02011581 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02011581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02011581 about?
NCT02011581 is a clinical study titled "Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People". The purpose of this research study is to learn more about how our body produces sugar, breaks down fat for fuel, and makes insulin (the major hormone that controls the production of blood sugar and fat breakdown) during a 24-hour day and how body fat and muscle are involved in these processes.
What is the current status of trial NCT02011581?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-10. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT02011581?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.